Financial Results Revenue for the third quarter of 2024 was $16.8 million versus $21.9 million for the same period last year. Revenue for the Treatment Segment decreased to approximately $9.1 million ...
Third Quarter 2024 Strategic, Operational and Financial Highlights (Unaudited) Net revenue increased 35% year-over-year to $21.7 million in the third quarter of 2024. For the three months ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback